Carol Gallagher, Pharm.D.


Carol has served as a member of our board of directors since November 2017. Since October 2014, she has served as a partner with New Enterprise Associates, a venture capital firm. Prior to joining New Enterprise Associates, Carol served as a venture partner with Frazier Healthcare from October 2013 to September 2014. She served as the President and Chief Executive Officer of Calistoga Pharmaceuticals, Inc., a biopharmaceutical company, from 2008 to 2011, when the company was acquired by Gilead Sciences. From 2007 to 2008, Carol was the President and Chief Executive Officer of Metastatix, Inc., a biopharmaceutical company. Between 1989 to 2007, she served in various roles at pharmaceutical companies Eli Lilly, Amgen, Agouron Pharmaceuticals, Pfizer, Biogen Idec Pharmaceuticals, CancerVax and Anadys Pharmaceuticals. Carol attended Vanderbilt University and received B.S. and Doctor of Pharmacy degrees from the University of Kentucky